Study Of Sunitinib With Capecitabine In Breast Cancer

Clinical trial NCT00662025 · COMPLETED

Trial details

NCT number: NCT00662025
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Breast Cancer

Start date: 2008-04-01
Primary completion: 2009-12-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.